[Date Prev][Date Next][Thread Prev][Thread Next][Date Index][Thread Index]

E-DRUG: Asthma medication - Ketotifen


  • Subject: E-DRUG: Asthma medication - Ketotifen
  • From: "R. Perez-Padilla" <perezpad@servidor.unam.mx>
  • Date: Thu, 23 Oct 1997 20:37:00 -0400 (EDT)


E-DRUG: Asthma medication - Ketotifen
-------------------------------------
I am reviewing facts about ketotifen (Zaditen from the previous 
Sandoz and other companies), promoted heavily for asthma in Mexico 
and selling 17% of all antiasthmatic drugs. The references they 
provide are very questionable.  I would be interested in andy 
information regarding ketotifen especially data difficult to obtain in 
Medline for example:

a) what is the situation with U.S. FDA approval and approvals for 
asthma in other developed countries?

b) information about marketing policies

c) Opinions of reviewers for international guidelines of asthma 
treatment (about ketotifen)

d) international sales in other developing countries 

Rogelio Perez-Padilla MD
Tlalpan 4502, 
Mexico DF 14080
Mexico
Tel and FAX 525-6668640
Email: perezpad@servidor.unam.mx

--
Send mail for the `E-Drug' conference to `e-drug@usa.healthnet.org'.
Mail administrative requests to `majordomo@usa.healthnet.org'.
For additional assistance, send mail to:  `owner-e-drug@usa.healthnet.org'.